A(H1N2) viruses have emerged through multiple reassortment events involving avian, swine, and human influenza viruses. These reassortments have resulted in various genetic compositions of A(H1N2) viruses in swine populations globally. In humans, A(H1N2) viruses have arisen from the reassortment of human A(H1N1) and A(H3N2) strains, leading to the circulation of A(H1N2) viruses with specific genetic characteristics. Rare instances of direct cross-species transmission from swine to humans have been reported, with notable cases in Minnesota in 2012, where swine-origin A(H1N2)v viruses were detected in humans.
Related Posts
Scientists Paving the Way for New Treatments: A Look at Some of the Most Promising Research
A new machine learning approach developed by researchers at MIT and Harvard University could help scientists more efficiently design experiments to engineer cells into new states. This could have a significant impact on the development of new therapies for cancer, regenerative medicine, and other diseases. The new approach leverages the cause-and-effect relationship between factors in […]
How Ancient Egyptians Shed Light on Heart Disease Today?
For ages, Egyptian mummies have enthralled us with their mysteries and hints of a forgotten civilization trapped in the sands of time. However, these stories are more than simply whispers; they are testaments to human tenacity, cultural norms, and even…heart disease. That’s correct! An Egyptian mummy provides the oldest evidence of atherosclerosis, which is a […]
Precision in cancer treatment: Nano drones target tumor cells precisely.
Revolutionary nano-drones offer precise cancer treatment by delivering medications directly to tumor sites. These minuscule devices navigate through the body, guided by specific targeting mechanisms, and carry drugs or therapeutic agents to affected areas. This targeted drug delivery minimizes damage to healthy tissues, enhancing treatment effectiveness while reducing side effects. The nanodrones’ ability to access […]